Clinical Trial Update: Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in mCRC [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating monosialotetrahexosylganglioside sodium injection to prevent neurotoxicity from mFOLFOX6 in metastatic colorectal cancer;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Monosialotetrahexosylganglioside Sodium Injection (monosialotetrahexosylganglioside sodium)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Colorectal Cancer | Phase 3 | Status: UNKNOWN